By supporting mitochondrial function, they ensure that cells efficiently convert nutrients into energy, promoting overall metabolic health
Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]
Shortly thereafter, though, Petty started experiencing symptoms often associated with perimenopause, such as mood swings, anxiety, irregular periods and hot flashes
GLP-1 treatment protects against EndMT through inhibiting the activation of poly (ADP-ribose) polymerase 1 (PARP-1) which can elicit Smad3 and transforming growth factor (TGF)-1 responses
Quick Answer: Tirzepatide does not directly cause gallstones, but its rapid weight loss effects increase gallstone risk, with clinical trials showing cholelithiasis in 2.5% of treated patients versus 1.0% on placebo
doi: 10.1002/jbmr.5650101203